Mogroside III-E

Basic Information

View in Editor

CAS Number

88901-37-5

Molecular Formula

C48H82O19

Molecular Weight

963.17 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

Density

1.40±0.1 g/cm3 (20 ºC 760 Torr),

Solubility

Insuluble (2.6E-4 g/L) (25 ºC),

SMILES

View in Editor

CC(CCC(C(C)(C)O)OC1C(C(C(C(O1)CO)O)O)OC2C(C(C(C(O2)CO)O)O)O)C3CCC4(C3(CC(C5(C4CC=C6C5CCC(C6(C)C)OC7C(C(C(C(O7)CO)O)O)O)C)O)C)C

InChI

InChI=1S/C48H82O19/c1-21(9-13-31(45(4,5)61)66-43-40(37(58)34(55)27(20-51)64-43)67-42-39(60)36(57)33(54)26(19-50)63-42)22-15-16-46(6)28-12-10-23-24(48(28,8)29(52)17-47(22,46)7)11-14-30(44(23,2)3)65-41-38(59)35(56)32(53)25(18-49)62-41/h10,21-22,24-43,49-61H,9,11-20H2,1-8H3/t21-,22-,24-,25-,26-,27-,28+,29-,30+,31-,32-,33-,34-,35+,36+,37+,38-,39-,40-,41+,42+,43+,46+,47-,48+/m1/s1

InChIKey

QATISCJMIITVAB-CNEPTXDISA-N

LogP

-1.055999999999986

Topological Polar Surface Area

318.37 Å²

Hydrogen Bond Donor/Acceptor

13 / 19

Complexity

1720

Safety Information

View Safety Information

GHS Hazard Pictograms

H302

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

Storage Conditions

2-8℃

Synonyms & References

English

a-D-Glucopyranoside,(3a,9a,10R,11R,24R)-3- (a-D-glucopyranosyloxy)-11,25-dihydroxy-9- methyl-19-norlanost-5-en-24-yl 2-O-a-D-glucopyranosyl-
Mogroside IIIe
(1S,4R,8β,9β,11α,24R)-1-(β-D-Glucopyranosyloxy)-11,25-dihydroxy-9 ,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-en-24-yl 2-O-β-D-gl ucopyranosyl-β-D-glucopyranoside
MOGROSIDE IIE
MOGROSIDE IIIE(P) PrintBack
â-D-Glucopyranoside,(3â,9â,10R,11R,24R)-3- (â-D-glucopyranosyloxy)-11,25-dihydroxy-9- methyl-19-norlanost-5-en-24-yl 2-O-â-D-glucopyranosyl-
mogroside Ⅲe
Mogroside III E
8173AH
Mogroside III-E
(3β,9β,10α,11α,24R)-3-(β-D-Glucopyranosyloxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside (ACI)
Mogroside e
DTXSID501316889
88901-37-5
CS-0027950
HY-N6928
AKOS030530146

MDL Number

MFCD28124365

FAQ

What regulatory guidelines apply to Mogroside III-E (CAS: 88901-37-5)?

Mogroside III-E (CAS: 88901-37-5) should comply with regulatory guidelines such as the Globally Harmonized System (GHS) for classification and labeling, as well as specific requirements under the European Union's REACH regulations. In the United States, it must adhere to FDA and EPA guidelines for safety and environmental protection.

Are there alternatives to Mogroside III-E in synthesis (CAS: 88901-37-5)?

Alternatives to Mogroside III-E in synthesis might include other mogrosides or natural sweeteners like stevia derivatives. Isomers or analogs such as mogroside IV or V can also be used as substitutes, depending on the specific application requirements.

What is the market or research trend for Mogroside III-E (CAS: 88901-37-5)?

The market for Mogroside III-E (CAS: 88901-37-5) is growing due to increasing demand in functional foods and dietary supplements. Research trends focus on its potential health benefits, such as anti-inflammatory and antioxidant properties, and its use in pharmaceuticals and cosmetics.

How should waste containing Mogroside III-E (CAS: 88901-37-5) be handled?

Waste containing Mogroside III-E (CAS: 88901-37-5) should be collected in appropriate containers, ensuring minimal environmental impact. Proper incineration or professional waste disposal services should be utilized. Always follow local environmental protection regulations and safety precautions to handle and dispose of the waste safely.